Russell Investments Group Ltd. raised its holdings in American Healthcare REIT, Inc. (NYSE:AHR - Free Report) by 6.4% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,580,473 shares of the company's stock after acquiring an additional 95,247 shares during the period. Russell Investments Group Ltd. owned about 1.00% of American Healthcare REIT worth $47,888,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds have also modified their holdings of the company. Wolff Wiese Magana LLC bought a new position in shares of American Healthcare REIT during the first quarter worth about $25,000. MassMutual Private Wealth & Trust FSB lifted its stake in American Healthcare REIT by 189.0% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 968 shares of the company's stock valued at $29,000 after acquiring an additional 633 shares during the last quarter. Spirit of America Management Corp NY acquired a new position in American Healthcare REIT during the first quarter worth approximately $30,000. Avalon Trust Co acquired a new stake in American Healthcare REIT during the 1st quarter valued at $36,000. Finally, Continuum Advisory LLC acquired a new stake in American Healthcare REIT during the first quarter worth approximately $37,000. 16.68% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several research analysts have commented on the stock. Robert W. Baird assumed coverage on shares of American Healthcare REIT in a research report on Friday, July 18th. They set an "outperform" rating and a $41.00 price objective for the company. KeyCorp raised their target price on American Healthcare REIT from $34.00 to $40.00 and gave the company an "overweight" rating in a report on Wednesday, June 11th. Scotiabank began coverage on shares of American Healthcare REIT in a research report on Monday, June 30th. They set a "sector outperform" rating and a $42.00 target price for the company. Morgan Stanley lifted their target price on shares of American Healthcare REIT from $37.00 to $45.00 and gave the company an "overweight" rating in a research report on Tuesday, May 20th. Finally, Truist Financial increased their price objective on American Healthcare REIT from $38.00 to $44.00 and gave the company a "buy" rating in a research note on Monday. Ten investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Buy" and an average price target of $41.11.
Read Our Latest Analysis on American Healthcare REIT
American Healthcare REIT Stock Performance
NYSE:AHR traded up $0.56 during trading hours on Monday, hitting $41.01. 593,399 shares of the company were exchanged, compared to its average volume of 1,633,053. The company has a debt-to-equity ratio of 0.41, a current ratio of 0.48 and a quick ratio of 0.48. The company's 50 day moving average price is $37.43 and its 200-day moving average price is $33.13. American Healthcare REIT, Inc. has a 52-week low of $18.91 and a 52-week high of $41.50. The stock has a market capitalization of $6.91 billion, a price-to-earnings ratio of -186.63, a PEG ratio of 2.24 and a beta of 1.08.
American Healthcare REIT (NYSE:AHR - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.42 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.02. American Healthcare REIT had a negative net margin of 1.56% and a negative return on equity of 1.43%. The business had revenue of $542.50 million for the quarter, compared to analysts' expectations of $539.49 million. During the same quarter last year, the company earned $0.33 EPS. The business's revenue was up 7.5% on a year-over-year basis. As a group, research analysts forecast that American Healthcare REIT, Inc. will post 1.41 earnings per share for the current year.
American Healthcare REIT Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, July 18th. Investors of record on Monday, June 30th were issued a $0.25 dividend. The ex-dividend date was Monday, June 30th. This represents a $1.00 dividend on an annualized basis and a yield of 2.4%. American Healthcare REIT's dividend payout ratio (DPR) is -454.55%.
Insider Transactions at American Healthcare REIT
In related news, CIO Stefan K.L. Oh sold 3,860 shares of the business's stock in a transaction on Monday, June 30th. The shares were sold at an average price of $36.10, for a total transaction of $139,346.00. Following the completion of the transaction, the executive owned 95,671 shares in the company, valued at approximately $3,453,723.10. The trade was a 3.88% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 1.00% of the company's stock.
American Healthcare REIT Company Profile
(
Free Report)
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.
Featured Stories

Before you consider American Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Healthcare REIT wasn't on the list.
While American Healthcare REIT currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.